Search research articles
Contact Us
Filters
Showing results (181-190 of 328) with videos related to
Page
of 33
Sort By:
Cytokine
|
September 27, 2012
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study
Bridget Charbonneau, Matthew J Maurer, Stephen M Ansell, et al.
American Journal of Hematology
|
March 28, 2019
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas
Sean I Tracy, Melissa C Larson, Andrew L Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2022
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, et al.
Blood
|
April 9, 2008
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial
Anton Hagenbeek, Ole Gadeberg, Peter Johnson, et al.
Leukemia & Lymphoma
|
June 14, 2021
Body mass index and survival of patients with lymphoma
Dai Chihara, Melissa C Larson, Dennis P Robinson, et al.
Cancer
|
June 22, 2021
Surveillance imaging during first remission in follicular lymphoma does not impact overall survival
Max L Goldman, Jimmy J Mao, Christopher S Strouse, et al.
American Journal of Hematology
|
March 1, 2019
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study
Yucai Wang, Thomas M Habermann, Sophia S Wang, et al.
Blood
|
July 19, 2011
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia
Matthew J Maurer, James R Cerhan, Jerry A Katzmann, et al.
British Journal of Haematology
|
June 28, 2017
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy
Umar Farooq, Matthew J Maurer, Carrie A Thompson, et al.
Blood Cancer Journal
|
July 18, 2021
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
Arushi Khurana, Raphael Mwangi, Stephen M Ansell, et al.
Page
of 33
Search research articles
Search
Showing results (181-190 of 328) with videos related to
Sort By:
Page
of 33
Cytokine
|
September 27, 2012
Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study
Bridget Charbonneau, Matthew J Maurer, Stephen M Ansell, et al.
American Journal of Hematology
|
March 28, 2019
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas
Sean I Tracy, Melissa C Larson, Andrew L Feldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 10, 2022
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium
Angie Mae Rodday, Susan K Parsons, Jenica N Upshaw, et al.
Blood
|
April 9, 2008
First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial
Anton Hagenbeek, Ole Gadeberg, Peter Johnson, et al.
Leukemia & Lymphoma
|
June 14, 2021
Body mass index and survival of patients with lymphoma
Dai Chihara, Melissa C Larson, Dennis P Robinson, et al.
Cancer
|
June 22, 2021
Surveillance imaging during first remission in follicular lymphoma does not impact overall survival
Max L Goldman, Jimmy J Mao, Christopher S Strouse, et al.
American Journal of Hematology
|
March 1, 2019
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study
Yucai Wang, Thomas M Habermann, Sophia S Wang, et al.
Blood
|
July 19, 2011
Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia
Matthew J Maurer, James R Cerhan, Jerry A Katzmann, et al.
British Journal of Haematology
|
June 28, 2017
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy
Umar Farooq, Matthew J Maurer, Carrie A Thompson, et al.
Blood Cancer Journal
|
July 18, 2021
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era
Arushi Khurana, Raphael Mwangi, Stephen M Ansell, et al.
Page
of 33